| 臺大學術典藏 |
2020-09-23T06:22:34Z |
Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma
|
Huang C.-T.; RUOH-FANG YEN; Cheng M.-F.; Hsu Y.-C.; Wei P.-F.; Tsai Y.-J.; Tsai M.-F.; Shih J.-Y.; Yang C.-H.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-23T15:27:51Z |
A comparative analysis of tunneling FET circuit switching characteristics and SRAM stability and performance
|
Chen, Y.-N.; Fan, M.-L.; Hu, P.-H.; Tsai, M.-F.; Pao, C.-H.; Su, P.; Chuang, C.-T. |
| 臺大學術典藏 |
2020-08-13T06:34:06Z |
Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer
|
JIN-YUAN SHIH; Gow C.-H.; Yu C.-J.; Yang C.-H.; Chang Y.-L.; Tsai M.-F.; Hsu Y.-C.; Chen K.-Y.; Su W.-P.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-13T06:33:59Z |
Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer
|
Gow C.-H.; Chang Y.-L.; Hsu Y.-C.; Tsai M.-F.; Wu C.-T.; Yu C.-J.; Yang C.-H.; Lee Y.-C.; Yang P.-C.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-08-13T06:33:57Z |
Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma
|
Yen R.-F.; Huang C.-T.; Huang C.-T.;Yen R.-F.;Cheng M.-F.;Hsu Y.-C.;Wei P.-F.;Tsai Y.-J.;Tsai M.-F.;Jin-Yuan Shih;Yang C.-H.;Yang P.-C.; Cheng M.-F.; Hsu Y.-C.; Wei P.-F.; Tsai Y.-J.; Tsai M.-F.; JIN-YUAN SHIH; Yang C.-H.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-13T06:33:54Z |
Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor
|
Lin S.-B.; Wu C.-P.; JIN-YUAN SHIH; Yang P.-C.; Lan C.-C.; Yang C.-H.; Yu Y.-L.; Yu S.-L.; Huang C.-P.; Chang T.-H.; Tsai M.-F.; Su K.-Y.; Wu S.-G. |
| 臺大學術典藏 |
2020-08-13T06:33:52Z |
Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction
|
Lee Y.-C.; Tsai M.-F.; Wu S.-G.; Chang Y.-L.; Lin J.-W.; Wu C.-T.; Chen H.-Y.; Yu C.-J.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-08-13T06:33:50Z |
EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR
|
Tsai M.-F.; Yu C.-J.; Chen Y.-H.; JIN-YUAN SHIH; Chang Y.-L.; Kuo Y.-W.; Wu S.-G.; Wu S.-G.;Kuo Y.-W.;Chang Y.-L.;Jin-Yuan Shih;Chen Y.-H.;Tsai M.-F.;Yu C.-J.;Yang C.-H.;Yang P.-C.; Yang C.-H.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-13T06:33:50Z |
Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma
|
JIN-YUAN SHIH; Tsai T.-H.; Wu S.-G.; Chang Y.-L.; Wu C.-T.; Tsai M.-F.; Wei P.-F.; Yang C.-H.; Yu C.-J.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-13T06:33:47Z |
Survival of lung adenocarcinoma patients with malignant pleural effusion
|
Wu S.-G.; Yu C.-J.; Tsai M.-F.; Liao W.-Y.; Yang C.-H.; Jan I.-S.; Yang P.-C.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-08-13T06:33:46Z |
Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations
|
Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; JIN-YUAN SHIH; Liu Y.-N.; Tsai M.-F.; Tsai T.-H.; Yu C.-J.; Yang J.C.-H.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-13T06:33:44Z |
IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer
|
JIN-YUAN SHIH; Yang J.C.-H.; Yu S.-L.; Liu Y.-N.; Chang T.-H.; Tsai M.-F.; Wu S.-G.; Tsai T.-H.; Chen H.-Y. |
| 臺大學術典藏 |
2020-08-13T06:33:41Z |
EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway
|
Yang P.-C.; Hsu Y.-C.; Tsai M.-F.; Chang T.-H.; Wu S.-G.; Yang H.-Y.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-08-13T06:33:35Z |
Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C
|
Chang T.-H.;Tsai M.-F.;Gow C.-H.;Wu S.-G.;Liu Y.-N.;Chang Y.-L.;Yu S.-L.;Tsai H.-C.;Lin S.-W.;Chen Y.-W.;Kuo P.-Y.;Yang P.-C.;Jin-Yuan Shih; Wu S.-G.; Liu Y.-N.; Chang Y.-L.; Yu S.-L.; Tsai H.-C.; Lin S.-W.; Chen Y.-W.; Kuo P.-Y.; Yang P.-C.; JIN-YUAN SHIH; Chang T.-H.; Tsai M.-F.; Gow C.-H. |
| 臺大學術典藏 |
2020-08-13T06:33:30Z |
Oncogenic Function of a KIF5B-MET Fusion Variant in Non-Small Cell Lung Cancer
|
JIN-YUAN SHIH; Gow C.-H.;Liu Y.-N.;Li H.-Y.;Hsieh M.-S.;Chang S.-H.;Luo S.-C.;Tsai T.-H.;Chen P.-L.;Tsai M.-F.;Jin-Yuan Shih; Gow C.-H.; Liu Y.-N.; Li H.-Y.; Hsieh M.-S.; Chang S.-H.; Luo S.-C.; Tsai T.-H.; Chen P.-L.; Tsai M.-F. |
| 臺大學術典藏 |
2020-08-13T06:33:29Z |
IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer
|
Hsu C.-L.; Liu Y.-N.; Tsai M.-F.; Chang T.-H.; Wu S.-G.; Wu S.-G.;Chang T.-H.;Tsai M.-F.;Liu Y.-N.;Hsu C.-L.;Chang Y.-L.;Yu C.-J.;Jin-Yuan Shih; Chang Y.-L.; Yu C.-J.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-08-13T06:33:26Z |
Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer
|
Liu Y.-N.;Tsai M.-F.;Wu S.-G.;Chang T.-H.;Tsai T.-H.;Gow C.-H.;Chang Y.-L.;Jin-Yuan Shih; Liu Y.-N.; Tsai M.-F.; Wu S.-G.; Chang T.-H.; Tsai T.-H.; Gow C.-H.; Chang Y.-L.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-08-13T06:33:23Z |
MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process
|
Wang H.-Y.; Liu Y.-N.; Wu S.-G.; Hsu C.-L.; Chang T.-H.; Tsai M.-F.; Lin Y.-T.; JIN-YUAN SHIH; Wang H.-Y.;Liu Y.-N.;Wu S.-G.;Hsu C.-L.;Chang T.-H.;Tsai M.-F.;Lin Y.-T.;Jin-Yuan Shih |
| 臺大學術典藏 |
2020-08-12T08:25:31Z |
Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern
|
SHANG-GIN WU; Chang Y.-L.; Hsu Y.-C.; Wu J.-Y.; Yang C.-H.; Yu C.-J.; Tsai M.-F.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-12T08:25:29Z |
Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor
|
Chang T.-H.; Tsai M.-F.; Su K.-Y.; SHANG-GIN WU; Huang C.-P.; Yu S.-L.; Yu Y.-L.; Lan C.-C.; Yang C.-H.; Lin S.-B.; Wu C.-P.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-12T08:25:28Z |
Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma
|
Tsai T.-H.;Shang-Gin Wu;Chang Y.-L.;Wu C.-T.;Tsai M.-F.;Wei P.-F.;Yang C.-H.;Yu C.-J.;Yang P.-C.;Shih J.-Y.; Tsai T.-H.; SHANG-GIN WU; Chang Y.-L.; Wu C.-T.; Tsai M.-F.; Wei P.-F.; Yang C.-H.; Yu C.-J.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:28Z |
Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction
|
Shang-Gin Wu ;Chang Y.-L. ;Lin J.-W. ;Wu C.-T. ;Chen H.-Y. ;Tsai M.-F. ;Lee Y.-C. ;Yu C.-J. ;Shih J.-Y.; SHANG-GIN WU; Chang Y.-L.; Lin J.-W.; Wu C.-T.; Chen H.-Y.; Tsai M.-F.; Lee Y.-C.; Yu C.-J.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:27Z |
EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR
|
SHANG-GIN WU; Kuo Y.-W.; Chang Y.-L.; Shih J.-Y.; Chen Y.-H.; Tsai M.-F.; Yu C.-J.; Yang C.-H.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-12T08:25:26Z |
Survival of lung adenocarcinoma patients with malignant pleural effusion
|
Shang-Gin Wu;Yu C.-J.;Tsai M.-F.;Liao W.-Y.;Yang C.-H.;Jan I.-S.;Yang P.-C.;Shih J.-Y.; SHANG-GIN WU; Yu C.-J.; Tsai M.-F.; Liao W.-Y.; Yang C.-H.; Jan I.-S.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:25Z |
Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations
|
Tsai T.-H.; Yu C.-J.; Yang J.C.-H.; Yang P.-C.; Chen Y.-F.; Hsieh M.-S.; SHANG-GIN WU; Chang Y.-L.; Shih J.-Y.; Liu Y.-N.; Tsai M.-F. |
| 臺大學術典藏 |
2020-08-12T08:25:24Z |
IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer
|
Chen H.-Y.; Yu S.-L.; Yang J.C.-H.; Shih J.-Y.; Tsai T.-H.; SHANG-GIN WU; Tsai M.-F.; Chang T.-H.; Liu Y.-N. |
| 臺大學術典藏 |
2020-08-12T08:25:23Z |
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients
|
SHANG-GIN WU; Liu Y.-N.; Tsai M.-F.; Chang Y.-L.; Yu C.-J.; Yang P.-C.; Yang J.C.-H.; Wen Y.-F.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:23Z |
EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway
|
Shih J.-Y.; Tsai M.-F.; Chang T.-H.; SHANG-GIN WU; Yang H.-Y.; Hsu Y.-C.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-12T08:25:21Z |
Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C
|
Chang T.-H.;Tsai M.-F.;Gow C.-H.;Shang-Gin Wu;Liu Y.-N.;Chang Y.-L.;Yu S.-L.;Tsai H.-C.;Lin S.-W.;Chen Y.-W.;Kuo P.-Y.;Yang P.-C.;Shih J.-Y.; Chang T.-H.; Tsai M.-F.; Gow C.-H.; SHANG-GIN WU; Liu Y.-N.; Chang Y.-L.; Yu S.-L.; Tsai H.-C.; Lin S.-W.; Chen Y.-W.; Kuo P.-Y.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:19Z |
IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer
|
Shang-Gin Wu;Chang T.-H.;Tsai M.-F.;Liu Y.-N.;Hsu C.-L.;Chang Y.-L.;Yu C.-J.;Shih J.-Y.; SHANG-GIN WU; Chang T.-H.; Tsai M.-F.; Liu Y.-N.; Hsu C.-L.; Chang Y.-L.; Yu C.-J.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:18Z |
MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process
|
Wang H.-Y.;Liu Y.-N.;Shang-Gin Wu;Hsu C.-L.;Chang T.-H.;Tsai M.-F.;Lin Y.-T.;Shih J.-Y.; Wang H.-Y.; Liu Y.-N.; SHANG-GIN WU; Hsu C.-L.; Chang T.-H.; Tsai M.-F.; Lin Y.-T.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T06:35:51Z |
Transcription repressor Slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma
|
Liou G.-Y.; Lee M.-L.; Chen J.J.W.; Hong T.-M.; Yang S.-C.; Su J.-L.; Lee Y.-C.; Yang P.-C.; Shih J.-Y.;Tsai M.-F.;Chang T.-H.;Chang Y.-L.;Yuan A.;Chong-Jen Yu;Lin S.-B.;Liou G.-Y.;Lee M.-L.;Chen J.J.W.;Hong T.-M.;Yang S.-C.;Su J.-L.;Lee Y.-C.;Yang P.-C.; Shih J.-Y.; Tsai M.-F.; Chang T.-H.; Chang Y.-L.; Yuan A.; CHONG-JEN YU; Lin S.-B. |
| 臺大學術典藏 |
2020-08-12T06:35:35Z |
Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer
|
Gow C.-H.; Chang Y.-L.; Hsu Y.-C.; Tsai M.-F.; Wu C.-T.; CHONG-JEN YU; Yang C.-H.; Lee Y.-C.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T06:35:07Z |
Survival of lung adenocarcinoma patients with malignant pleural effusion
|
Wu S.-G.;Chong-Jen Yu;Tsai M.-F.;Liao W.-Y.;Yang C.-H.;Jan I.-S.;Yang P.-C.;Shih J.-Y.; Wu S.-G.; CHONG-JEN YU; Tsai M.-F.; Liao W.-Y.; Yang C.-H.; Jan I.-S.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:46:27Z |
Heparin co-factor II enhances cell motility and promotes metastasis in non-small cell lung cancer
|
Yu C.-J.; Lee C.-H.; Yang P.-C.; Lee Y.-C.; Chen H.-Y.; Liao W.-Y.; CHAO-CHI HO; Hou H.-H.; Hsu T.-H.; Tsai M.-F.; Chen K.-Y. |
| 臺大學術典藏 |
2020-07-21T06:25:19Z |
Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma
|
Yang P.-C.; Shih J.-Y.; Yu C.-J.; Yang C.-H.; TZU-HSIU TSAI; Wu S.-G.; Chang Y.-L.; Wu C.-T.; Tsai M.-F.; Wei P.-F. |
| 臺大學術典藏 |
2020-07-21T06:25:18Z |
Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations
|
Chen Y.-F.;Hsieh M.-S.;Wu S.-G.;Chang Y.-L.;Shih J.-Y.;Liu Y.-N.;Tsai M.-F.;Tzu-Hsiu Tsai;Yu C.-J.;Yang J.C.-H.;Yang P.-C.; Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; TZU-HSIU TSAI; Yu C.-J.; Yang J.C.-H.; Yang P.-C. |
| 臺大學術典藏 |
2020-07-21T06:25:17Z |
IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer
|
Shih J.-Y.; Liu Y.-N.;Chang T.-H.;Tsai M.-F.;Wu S.-G.;Tzu-Hsiu Tsai;Chen H.-Y.;Yu S.-L.;Yang J.C.-H.;Shih J.-Y.; Liu Y.-N.; Chang T.-H.; Tsai M.-F.; Wu S.-G.; TZU-HSIU TSAI; Chen H.-Y.; Yu S.-L.; Yang J.C.-H. |
| 臺大學術典藏 |
2020-07-21T06:25:16Z |
Oncogenic Function of a KIF5B-MET Fusion Variant in Non-Small Cell Lung Cancer
|
Shih J.-Y.; Gow C.-H.;Liu Y.-N.;Li H.-Y.;Hsieh M.-S.;Chang S.-H.;Luo S.-C.;Tzu-Hsiu Tsai;Chen P.-L.;Tsai M.-F.;Shih J.-Y.; Gow C.-H.; Liu Y.-N.; Li H.-Y.; Hsieh M.-S.; Chang S.-H.; Luo S.-C.; TZU-HSIU TSAI; Chen P.-L.; Tsai M.-F. |
| 臺大學術典藏 |
2020-07-21T06:25:15Z |
Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer
|
Liu Y.-N.;Tsai M.-F.;Wu S.-G.;Chang T.-H.;Tzu-Hsiu Tsai;Gow C.-H.;Chang Y.-L.;Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; Wu S.-G.; Chang T.-H.; TZU-HSIU TSAI; Gow C.-H.; Chang Y.-L.; Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:09:17Z |
Global expression profiling of theophylline response genes in macrophages: Evidence of airway anti-inflammatory regulation
|
Yao P.-L.;Tsai M.-F.;Lin Y.-C.;Wang C.-H.;Wei-Yu Liao;Chen J.J.W.;Yang P.-C.; Yao P.-L.; Tsai M.-F.; Lin Y.-C.; Wang C.-H.; WEI-YU LIAO; Chen J.J.W.; Yang P.-C. |
| 臺大學術典藏 |
2020-07-21T06:09:14Z |
Survival of lung adenocarcinoma patients with malignant pleural effusion
|
Wu S.-G.;Yu C.-J.;Tsai M.-F.;Wei-Yu Liao;Yang C.-H.;Jan I.-S.;Yang P.-C.;Shih J.-Y.; Wu S.-G.; Yu C.-J.; Tsai M.-F.; WEI-YU LIAO; Yang C.-H.; Jan I.-S.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:09:12Z |
Heparin co-factor II enhances cell motility and promotes metastasis in non-small cell lung cancer
|
Yang P.-C.; Lee C.-H.; Yu C.-J.; Hou H.-H.; Hsu T.-H.; Tsai M.-F.; Chen K.-Y.; Chen H.-Y.; Lee Y.-C.; Ho C.-C.; WEI-YU LIAO |
| 臺大學術典藏 |
2020-06-30T08:10:09Z |
Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor
|
Chang T.-H. ;Tsai M.-F. ;Kang-Yi Su ;Wu S.-G. ;Huang C.-P. ;Yu S.-L. ;Yu Y.-L. ;Lan C.-C. ;Yang C.-H. ;Lin S.-B. ;Wu C.-P. ;Shih J.-Y. ;Yang P.-C.; Chang T.-H.; Tsai M.-F.; KANG-YI SU; Wu S.-G.; Huang C.-P.; Yu S.-L.; Yu Y.-L.; Lan C.-C.; Yang C.-H.; Lin S.-B.; Wu C.-P.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-06-17T03:01:51Z |
Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor
|
Chang T.-H. ;Tsai M.-F. ;Su K.-Y. ;Wu S.-G. ;Huang C.-P. ;Sung-Liang Yu ;Yu Y.-L. ;Lan C.-C. ;Yang C.-H. ;Lin S.-B. ;Wu C.-P. ;Shih J.-Y. ;Yang P.-C.; Chang T.-H.; Tsai M.-F.; Su K.-Y.; Wu S.-G.; Huang C.-P.; SUNG-LIANG YU; Yu Y.-L.; Lan C.-C.; Yang C.-H.; Lin S.-B.; Wu C.-P.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-06-17T03:01:31Z |
Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C
|
Chang T.-H.;Tsai M.-F.;Gow C.-H.;Wu S.-G.;Liu Y.-N.;Chang Y.-L.;Sung-Liang Yu;Tsai H.-C.;Lin S.-W.;Chen Y.-W.;Kuo P.-Y.;Yang P.-C.;Shih J.-Y.; Chang T.-H.; Tsai M.-F.; Gow C.-H.; Wu S.-G.; Liu Y.-N.; Chang Y.-L.; SUNG-LIANG YU; Tsai H.-C.; Lin S.-W.; Chen Y.-W.; Kuo P.-Y.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-06-11T06:46:02Z |
Abbe-PCA (Abbe-Hopkins): Microlithography aerial image analytical compact kernel generation based on principle component analysis
|
Tsai, M.-F.;Chang, S.-J.;Chen, C.C.P.;Melvin III, L.S.; Tsai, M.-F.; Chang, S.-J.; Chen, C.C.P.; Melvin III, L.S.; CHUNG-PING CHEN |
| 臺大學術典藏 |
2020-06-11T06:45:59Z |
Accurate and analytical statistical spatial correlation modeling based on singular value decomposition for VLSI DFM applications
|
Liu, J.-H.;Tsai, M.-F.;Chen, L.;Chen, C.C.-P.; Liu, J.-H.; Tsai, M.-F.; Chen, L.; Chen, C.C.-P.; CHUNG-PING CHEN |
| 臺大學術典藏 |
2020-05-26T09:27:27Z |
Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer
|
Shih J.-Y;Gow C.-H;Yu C.-J;Chih-Hsin Yang;Chang Y.-L;Tsai M.-F;Hsu Y.-C;Chen K.-Y;Su W.-P;Yang P.-C.; Shih J.-Y; Gow C.-H; Yu C.-J; CHIH-HSIN YANG; Chang Y.-L; Tsai M.-F; Hsu Y.-C; Chen K.-Y; Su W.-P; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:21Z |
Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern
|
Yang P.-C.;Shih J.-Y;Tsai M.-F;Yu C.-J;Chih-Hsin Yang;Wu J.-Y;Hsu Y.-C;Chang Y.-L;Wu S.-G; Wu S.-G; Chang Y.-L; Hsu Y.-C; Wu J.-Y; CHIH-HSIN YANG; Yu C.-J; Tsai M.-F; Shih J.-Y; Yang P.-C. |
